CN1738610A - 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 - Google Patents
眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 Download PDFInfo
- Publication number
- CN1738610A CN1738610A CNA2004800022289A CN200480002228A CN1738610A CN 1738610 A CN1738610 A CN 1738610A CN A2004800022289 A CNA2004800022289 A CN A2004800022289A CN 200480002228 A CN200480002228 A CN 200480002228A CN 1738610 A CN1738610 A CN 1738610A
- Authority
- CN
- China
- Prior art keywords
- eye
- treating
- percutaneous absorption
- medicine
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
No. | 实施例1 | 比较例1 | |
剂型 | 经皮吸收型制剂 | 滴眼液 | |
药物 | 富马酸酮替芬 | 富马酸酮替芬 | |
结膜转移量(μg/g) | 1小时 | 0.06±0.02 | 0.03±0.01 |
12小时 | 0.10±0.02 | 0.02±0.01 |
No. | 实施例2 | 比较例2 | |
剂型 | 经皮吸收型制剂 | 滴眼液 | |
药物 | 二氯芬酸钠 | 二氯芬酸钠 | |
结膜转移量(μg/g) | 1小时 | 0.10±0.03 | 0.06±0.01 |
12小时 | 0.05±0.01 | N.D. |
组成 | |
富马酸酮替芬 | 0.3g(10wt.%) |
聚氧乙烯油醚 | 0.6g(20wt.%) |
肉豆蔻酸异丙酯 | 0.6g(20wt.%) |
丙烯酸类粘胶剂日本カ-バイド工业制“ニッセツPE-300” | 1.485g(固体成分) |
交联剂日本カ-バイド工业制“ニッセツCK-401” | 0.0015g |
时间 | 上下眼睑部贴敷 | 背部贴敷 | |
贴眼的结膜 | 未贴敷眼的结膜 | 两眼结膜 | |
4 | 4.44 | 0.39 | 0.01 |
8 | 2.95 | 0.03 | 0.02 |
24 | 0.13 | 0.01 | 0.01 |
成分 | [wt.%] | |
富马酸酮替芬 | 药剂 | 10.0 |
SIS类粘胶剂 | 粘胶剂 | 76.7 |
KOH | 促经皮吸收剂 | 2.5 |
棕榈酸异丙酯 | 促经皮吸收剂 | 10.0 |
丁羟基甲苯 | 抗氧化剂 | 0.8 |
时间 | 下眼睑部贴敷 | |||
结膜[μg/g·tissue] | 泪液[μg/mL] | |||
贴敷眼的结膜 | 未贴敷眼的结膜 | 贴敷眼的泪液 | 未贴敷眼的泪液 | |
4 | 0.0464±0.013 | N.D. | 0.054±0.052 | N.D. |
8 | 0.078±0.046 | 0.011±0.020 | 0.193±0.139 | N.D. |
组 | 抑制率[%] | 例数 |
Zaditen滴眼0.5hr | 80.7±1.6 | 5 |
Zaditen滴眼4hr | 46.34±4.8 | 6 |
Zaditen滴眼8hr | 32.8±15.0 | 6 |
实施例4制剂贴敷0.5hr | 42.4±3.2 | 6 |
实施例4制剂贴敷4hr | 79.5±3.5 | 5 |
实施例4制剂贴敷8hr | 83.4±1.0 | 6 |
实施例4制剂贴敷2hr剥离8hr后 | 75.4±1.9 | 6 |
Claims (20)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP013339/2003 | 2003-01-22 | ||
JP2003013339 | 2003-01-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013100373290A Division CN103127033A (zh) | 2003-01-22 | 2004-01-22 | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1738610A true CN1738610A (zh) | 2006-02-22 |
Family
ID=32767356
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004800022289A Pending CN1738610A (zh) | 2003-01-22 | 2004-01-22 | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 |
CN2013100373290A Pending CN103127033A (zh) | 2003-01-22 | 2004-01-22 | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013100373290A Pending CN103127033A (zh) | 2003-01-22 | 2004-01-22 | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060036220A1 (zh) |
EP (1) | EP1591110B1 (zh) |
JP (1) | JP4629578B2 (zh) |
KR (3) | KR20050092429A (zh) |
CN (2) | CN1738610A (zh) |
ES (1) | ES2534904T3 (zh) |
WO (1) | WO2004064817A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107375251A (zh) * | 2017-08-15 | 2017-11-24 | 徐静 | 一种含酮替芬的缓释透皮贴剂及其应用 |
CN108883308A (zh) * | 2016-01-26 | 2018-11-23 | 利维申制药有限公司 | α-肾上腺素能药剂的组合物和用途 |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005068101A (ja) * | 2003-08-27 | 2005-03-17 | Nippon Tenganyaku Kenkyusho:Kk | 眼瞼皮膚適用型外用剤 |
CN1819846A (zh) * | 2004-05-21 | 2006-08-16 | 千寿制药株式会社 | 包含毒蕈碱性受体激动剂的经皮肤吸收的眼用制剂 |
EP1852106A4 (en) * | 2005-02-17 | 2009-08-26 | Senju Pharma Co | SOLID OPHTHALMIC MEDICINE FOR EXTERNAL USE |
US20060210616A1 (en) * | 2005-03-17 | 2006-09-21 | Linder Barry J | Therapeutic patch for ophthalmologic and cosmetic use |
JP4924837B2 (ja) * | 2005-04-20 | 2012-04-25 | 千寿製薬株式会社 | 経皮吸収製剤 |
WO2007007851A1 (en) * | 2005-07-08 | 2007-01-18 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising epinastine |
ES2437077T3 (es) * | 2005-07-08 | 2014-01-08 | Senju Pharmaceutical Co., Ltd. | Preparado oftálmico de absorción percutánea que comprende olopatadina |
WO2007013661A1 (ja) * | 2005-07-26 | 2007-02-01 | Senju Pharmaceutical Co., Ltd. | 眼科用経皮吸収型製剤 |
EP1992363B1 (en) * | 2006-02-28 | 2012-12-19 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal absorption preparation |
WO2008026756A1 (en) * | 2006-08-28 | 2008-03-06 | Senju Pharmaceutical Co., Ltd. | Ophthalmic percutaneous absorption type preparation |
US8281445B2 (en) | 2006-11-03 | 2012-10-09 | Ocusoft, Inc. | Heated eyelid cleanser |
WO2008100647A1 (en) * | 2007-01-09 | 2008-08-21 | Bjl Medical, Llc | Therapeutic cooling pad for ophthalmologic and cosmetic use |
CN101909651B (zh) * | 2007-11-22 | 2013-11-06 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
US20090297590A1 (en) * | 2008-05-30 | 2009-12-03 | Masahiro Yamaji | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
HUE046071T2 (hu) * | 2009-10-30 | 2020-01-28 | Intratus Inc | Eljárások és készítmények gyógyszerek elnyújtott hatóanyagleadására |
US8721572B1 (en) | 2010-06-10 | 2014-05-13 | Eyedetec Medical, Inc. | Systems, devices, kits and methods for therapy of the eye |
FR2965272B1 (fr) * | 2010-09-27 | 2014-07-11 | Bostik Sa | Nouveaux auto-adhesifs thermofusibles extrudables pour films multicouches |
US8900626B2 (en) | 2011-06-20 | 2014-12-02 | Senju Usa, Inc. | Transdermal drug delivery system and method of using the same |
WO2013090842A2 (en) | 2011-12-16 | 2013-06-20 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam-polyvinyl acetate-polyethylene glycol graft copolymers |
US10543275B2 (en) * | 2012-06-20 | 2020-01-28 | Medrx Co., Ltd. | Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder |
US9211397B2 (en) | 2012-12-19 | 2015-12-15 | Senju Usa, Inc. | Patch for treatment of eyelid disease containing clobetasol |
US9278079B2 (en) | 2013-07-12 | 2016-03-08 | Ocusoft, Inc. | Ocular composition and kits thereof |
CN107148284A (zh) * | 2015-01-30 | 2017-09-08 | 株式会社梅德瑞科思 | 水性外用制剂 |
TW201705956A (zh) * | 2015-05-12 | 2017-02-16 | 參天製藥股份有限公司 | 唑系抗真菌藥之對眼瞼皮膚的投與 |
KR101782406B1 (ko) | 2015-06-11 | 2017-09-27 | 김철민 | 기능성 마네킹 |
WO2017037812A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 酸捕捉剤を含有する貼付製剤 |
US10016502B2 (en) | 2015-08-29 | 2018-07-10 | Medrx Co., Ltd | Patch preparation containing an acid scavenger |
TWI713618B (zh) * | 2015-10-29 | 2020-12-21 | 日商帝化製藥股份有限公司 | 外用劑 |
JP7183041B2 (ja) * | 2016-06-29 | 2022-12-05 | センジュ ユーエスエー、インコーポレイテッド | 経皮薬物送達システムおよびその使用方法 |
AU2021381495A1 (en) | 2020-11-23 | 2023-06-22 | Sight Sciences, Inc. | Formulations and methods for treating conditions of the eye |
JP7124248B1 (ja) | 2020-12-24 | 2022-08-23 | 参天製薬株式会社 | エピナスチン又はその塩を含有する塗布投与用医薬組成物 |
JP7171971B1 (ja) | 2020-12-24 | 2022-11-15 | 参天製薬株式会社 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069307A (en) * | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
US4052505A (en) * | 1975-05-30 | 1977-10-04 | Alza Corporation | Ocular therapeutic system manufactured from copolymer |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US4134401A (en) * | 1977-05-24 | 1979-01-16 | Galician Kenneth M | Eye-patching method and device |
US5364628A (en) * | 1985-05-31 | 1994-11-15 | Sandoz Ltd. | Pharmaceutical compositions |
US4931279A (en) * | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
WO1992003133A1 (en) * | 1990-08-16 | 1992-03-05 | Bloom, Leonard | Topical treatment of blepharitis |
JPH08509202A (ja) * | 1992-07-08 | 1996-10-01 | ディアノルム―ゲレーテ・ゲー・マイエルホファー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | リポソーム、それを調製する方法及び薬調製におけるその用途 |
DE4313928C2 (de) * | 1993-04-28 | 1996-09-19 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung |
US6309630B1 (en) * | 1994-05-24 | 2001-10-30 | Insite Vision Incorporated | Non-steroidal anti-inflammatory ophthalmic suspensions |
JP3908795B2 (ja) * | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | ケトチフェン含有経皮投与製剤 |
EP0807434B1 (en) * | 1995-01-20 | 2002-04-10 | Wakamoto Pharmaceutical Co., Ltd. | Anti-inflammatory eyedrops |
US6678553B2 (en) * | 1995-11-21 | 2004-01-13 | Intraabrain International Nv | Device for enhanced delivery of biologically active substances and compounds in an organism |
SI0812588T1 (en) * | 1995-12-28 | 2005-02-28 | Mitsubishi Pharma Corporation | Pharmaceutical external preparations for topical administration comprising 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for the treatment of diseases induced from immune disorder |
US6193996B1 (en) * | 1998-04-02 | 2001-02-27 | 3M Innovative Properties Company | Device for the transdermal delivery of diclofenac |
DK1075265T3 (da) * | 1998-05-08 | 2006-06-26 | Univ Miami | Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler |
RU2125427C1 (ru) * | 1998-05-27 | 1999-01-27 | Миронова Эмилия Михайловна | Средство для лечения глазных заболеваний - оковидит |
JP2000256214A (ja) | 1999-03-08 | 2000-09-19 | Nichiban Co Ltd | 消炎鎮痛貼付剤 |
US6777429B1 (en) * | 1999-07-23 | 2004-08-17 | Novartis Ag | Ophthalmic composition |
IT1313610B1 (it) * | 1999-08-09 | 2002-09-09 | S I F I Societa Ind Farmaceuti | Processo per la preparazione di formulazioni acquose per uso oftalmico |
JP2001131064A (ja) * | 1999-08-25 | 2001-05-15 | Nippon Tenganyaku Kenkyusho:Kk | トラニラスト膏体組成物及びその製造方法 |
US6624193B1 (en) * | 1999-09-06 | 2003-09-23 | Ono Pharmaceutical Co., Ltd. | Preventive and therapeutic agents for eye diseases |
US7052714B1 (en) * | 1999-10-13 | 2006-05-30 | Senju Pharmaceutical Co., Ltd | Ophthalmic adhesive preparations for percutaneous adsorption |
BR0015647A (pt) * | 1999-11-18 | 2002-07-16 | Alcon Inc | Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos |
US6395756B2 (en) * | 1999-12-23 | 2002-05-28 | Novartis Ag | Use of ophthalmic agent |
US6277855B1 (en) | 2000-04-21 | 2001-08-21 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
CZ2003783A3 (cs) * | 2000-09-18 | 2003-06-18 | Laboratoires Fournier Sa | Náplast obsahující diclofenac |
EP1350512A1 (en) * | 2002-04-03 | 2003-10-08 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
US20040224010A1 (en) * | 2002-11-15 | 2004-11-11 | Optime Therapeutics, Inc. | Ophthalmic liposome compositions and uses thereof |
TWI341838B (en) * | 2003-09-17 | 2011-05-11 | Ono Pharmaceutical Co | Carboxylic acid compound and pharmaceutical composition containg same as active ingredient |
ES2437077T3 (es) * | 2005-07-08 | 2014-01-08 | Senju Pharmaceutical Co., Ltd. | Preparado oftálmico de absorción percutánea que comprende olopatadina |
US8900626B2 (en) * | 2011-06-20 | 2014-12-02 | Senju Usa, Inc. | Transdermal drug delivery system and method of using the same |
GB201214750D0 (en) * | 2012-08-17 | 2012-10-03 | Respivert Ltd | Compounds |
-
2004
- 2004-01-22 ES ES04704362.5T patent/ES2534904T3/es not_active Expired - Lifetime
- 2004-01-22 US US10/540,835 patent/US20060036220A1/en not_active Abandoned
- 2004-01-22 JP JP2005508112A patent/JP4629578B2/ja not_active Expired - Fee Related
- 2004-01-22 CN CNA2004800022289A patent/CN1738610A/zh active Pending
- 2004-01-22 CN CN2013100373290A patent/CN103127033A/zh active Pending
- 2004-01-22 EP EP04704362.5A patent/EP1591110B1/en not_active Expired - Lifetime
- 2004-01-22 KR KR1020057013282A patent/KR20050092429A/ko not_active Application Discontinuation
- 2004-01-22 WO PCT/JP2004/000520 patent/WO2004064817A1/ja active Application Filing
- 2004-01-22 KR KR1020137025989A patent/KR20130121196A/ko not_active Application Discontinuation
- 2004-01-22 KR KR1020127004416A patent/KR20120035220A/ko active Search and Examination
-
2010
- 2010-02-25 US US12/712,459 patent/US20100150992A1/en not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108883308A (zh) * | 2016-01-26 | 2018-11-23 | 利维申制药有限公司 | α-肾上腺素能药剂的组合物和用途 |
US11311476B2 (en) | 2016-01-26 | 2022-04-26 | Levation Pharma Ltd. | Compositions and uses of alpha-adrenergic agents |
CN115006537A (zh) * | 2016-01-26 | 2022-09-06 | 利维申制药有限公司 | α-肾上腺素能药剂的组合物和用途 |
US11491104B2 (en) | 2016-01-26 | 2022-11-08 | Levation Pharma Ltd. | Compositions and uses of alpha-adrenergic agents |
CN107375251A (zh) * | 2017-08-15 | 2017-11-24 | 徐静 | 一种含酮替芬的缓释透皮贴剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
KR20130121196A (ko) | 2013-11-05 |
ES2534904T3 (es) | 2015-04-30 |
WO2004064817A1 (ja) | 2004-08-05 |
JPWO2004064817A1 (ja) | 2006-05-18 |
KR20050092429A (ko) | 2005-09-21 |
EP1591110A4 (en) | 2007-08-15 |
CN103127033A (zh) | 2013-06-05 |
US20100150992A1 (en) | 2010-06-17 |
JP4629578B2 (ja) | 2011-02-09 |
EP1591110A1 (en) | 2005-11-02 |
KR20120035220A (ko) | 2012-04-13 |
EP1591110B1 (en) | 2015-03-18 |
US20060036220A1 (en) | 2006-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1738610A (zh) | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 | |
CN1245961C (zh) | 紫外遮蔽性贴剂 | |
CN103429295B (zh) | 透皮给药系统及其使用方法 | |
KR100846642B1 (ko) | 첩부제 | |
CN1720028A (zh) | 降低了滥用可能的经皮止痛系统 | |
JP4308255B2 (ja) | ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤 | |
CN101528211B (zh) | 眼用经皮吸收型制剂 | |
CN101032474A (zh) | 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法 | |
CN1409628A (zh) | 贴剂 | |
EP2296748B1 (en) | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease | |
EP1221315A1 (en) | Ophthalmic adhesive preparations for percutaneous absorption | |
CN1240350A (zh) | 含有5-羟色胺受体拮抗剂的经皮给药制剂 | |
CN1907273A (zh) | 烟碱透皮制剂的制备方法 | |
KR102499141B1 (ko) | 수면장애 치료용 경피흡수제제 | |
KR20150095895A (ko) | 클로베타솔을 함유하는 눈꺼풀 질환의 치료용 패치 | |
KR101395557B1 (ko) | 경피 흡수 제제 및 그 제조방법 | |
CN1252004A (zh) | 经皮吸收用基质组合物及含有该基质组合物的可经皮吸收的制剂 | |
TW201542249A (zh) | 含畢索普洛(bisoprolol)之貼附製劑 | |
TWI780179B (zh) | 含有利伐斯的明之經皮吸收型製劑 | |
CN105326817A (zh) | 一种用于治疗眼疾的经皮吸收型制剂 | |
WO2007013661A1 (ja) | 眼科用経皮吸収型製剤 | |
CN109806243A (zh) | 一种含有氟吡汀或其药用盐的皮肤外用贴剂 | |
CN117899056A (zh) | 含利多卡因的透皮贴剂及其制备方法和用途 | |
WO2015034053A1 (ja) | ビソプロロール含有貼付製剤 | |
JPH05294832A (ja) | 経皮吸収貼付剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SENJU USA CO., LTD.; APPLICANT Free format text: FORMER OWNER: NICHIBAN COMPANY LTD.; APPLICANT Effective date: 20080509 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080509 Address after: California, USA Applicant after: Thousands of longevity American companies Co-applicant after: SENJU PHARMA CO(JP) Address before: Tokyo Applicant before: Japan stumbling Corporation Co-applicant before: SENJU PHARMA CO(JP) |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090213 Address after: Osaka Japan Applicant after: SENJU PHARMA CO(JP) Address before: California, USA Applicant before: Thousands of longevity American companies Co-applicant before: SENJU PHARMA CO(JP) |
|
ASS | Succession or assignment of patent right |
Owner name: SENJU PHARMA CO., LTD. Free format text: FORMER OWNER: SENJU USA CO., LTD. Effective date: 20090213 |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20060222 |